Eyad ALMOUAZEN

Maitre de conférences

  • Génie Pharmacotechnique


Bureau 2 Rockefeller

Bureau 1 Université Claude Bernard Lyon 1, bât 308G ESCPE-Lyon, 43 bd du 11 Novembre 1918 G207 Villeurbanne Cedex 69622 France

Téléphone bureau 2: 04 78 77 71 15Téléphone bureau 1: 0472431835

Microencapsulation of rifampicin for the prevention of endophthalmitis: In vitro release studies and antibacterial assessment

date:2016
références bibliographiques:

Lee, Mi Yeon, Sandrine Bourgeois, Eyad Almouazen, Jocelyne Pelletier, François Renaud, Hatem Fessi, and Laurent Kodjikian. “Microencapsulation of Rifampicin for the Prevention of Endophthalmitis: In Vitro Release Studies and Antibacterial Assessment.” , March 2016. doi:10.1016/j.ijpharm.2016.03.026.

International Journal of Pharmaceutics

 

Nano-encapsulation of Vitamin D3 Active Metabolites for Application in Chemotherapy: Formulation Study and in Vitro Evaluation

date:2012
références bibliographiques:

Almouazen, Eyad, Sandrine Bourgeois, Lars Petter Jordheim, Hatem Fessi, and Stephanie Briançon. “Nano-Encapsulation of Vitamin D3 Active Metabolites for Application in Chemotherapy: Formulation Study and in Vitro Evaluation.” , December 8, 2012. doi:10.1007/s11095-012-0949-4.

Pharmaceutical Research

 

Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages

date:2012
références bibliographiques:

Almouazen, Eyad, Sandrine Bourgeois, Ali Boussaïd, Pascale Valot, Celine Malleval, Hatem Fessi, Serge Nataf, and Stephanie Briançon. “Development of a Nanoparticle-Based System for the Delivery of Retinoic Acid into Macrophages.” 430, no. 1–2 (July 2012): 207–15. https://doi.org/10.1016/j.ijpharm.2012.03.025.
Pages:207-215

International Journal of Pharmaceutics